ENDOLOGIX INC /DE/ — Form D

ENDOLOGIX INC /DE/ of Irvine, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-22. The offering totals $210.5M, of which $210.5M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
Dan LemaitreDirectorIrvine, CA
Guido J NeelsDirectorIrvine, CA
Leslie V NorwalkDirectorIrvine, CA
John OnopchenkoDirectorIrvine, CA
Gregory D WallerDirectorDallas, TX
Thomas C Wilder IIIDirectorIrvine, CA
Thomas D Zenty IIIDirectorIrvine, CA
Jeremy HaydenExecutive OfficerIrvine, CA
Vaseem MahboobExecutive OfficerIrvine, CA
John OnopchenkoExecutive OfficerIrvine, CA
Matthew ThompsonExecutive OfficerSanta Monica, CA
Robert D MitchellExecutive OfficerToronto, A6
John McDermottDirectorCambridge, MA
John McDermottExecutive OfficerCambridge, MA
Daniel G LemaitreDirectorIrvine, CA
Leslie J NorwalkDirectorIrvine, CA
Christopher G ChavezDirectorIrvine, CA
Thomas C III WilderDirectorIrvine, CA
Thomas F III ZentyDirectorIrvine, CA
Vaseem D MahboobExecutive OfficerIrvine, CA
Jeffrey F O'DonnellDirectorKing of Prussia, PA
Franklin D BrownDirectorIrvine, CA
Dan D LemaitreDirectorIrvine, CA
Robert John KristExecutive OfficerIrvine, CA
Roderick D De GreefDirectorIrvine, CA

Other filings by this issuer (3)

FiledFormOfferingSold
2017-04-07D$179.7M$179.7M
2010-12-21D$53.8M$14.8M
2010-12-21D$15.0M$15.0M

More